Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpha-Emitting Radionuclides: Current Status and Future Perspectives.
Miederer M, Benešová-Schäfer M, Mamat C, Kästner D, Pretze M, Michler E, Brogsitter C, Kotzerke J, Kopka K, Scheinberg DA, McDevitt MR. Miederer M, et al. Among authors: mcdevitt mr. Pharmaceuticals (Basel). 2024 Jan 8;17(1):76. doi: 10.3390/ph17010076. Pharmaceuticals (Basel). 2024. PMID: 38256909 Free PMC article. Review.
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.
Kurtz K, Eibler L, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C, Monette S, Punzalan B, Khayat S, Verma S, Kesner AL, Cheung NV, Schöder H, Gajecki L, Cheal SM, Larson SM, Scheinberg DA, Krebs S. Kurtz K, et al. Among authors: mcdevitt mr. Theranostics. 2023 Oct 8;13(15):5469-5482. doi: 10.7150/thno.87489. eCollection 2023. Theranostics. 2023. PMID: 37908719 Free PMC article.
Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B, Patel M, Xu H, Guo HF, Zanzonico PB, Monette S, Yang G, Ouerfelli O, Nash GM, Cercek A, Fung EK, Howell RW, Larson SM, Cheal SM, Cheung NV. Chung SK, et al. Among authors: mcdevitt mr. J Nucl Med. 2023 Sep;64(9):1439-1445. doi: 10.2967/jnumed.122.265095. Epub 2023 Jun 22. J Nucl Med. 2023. PMID: 37348919 Free PMC article.
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.
Storey CM, Altai M, Bicak M, Veach DR, Lückerath K, Adrian G, McDevitt MR, Kalidindi T, Park JE, Herrmann K, Abou D, Zedan W, Peekhaus N, Klein RJ, Damoiseaux R, Larson SM, Lilja H, Thorek D, Ulmert D. Storey CM, et al. Among authors: mcdevitt mr. Mol Cancer Res. 2023 Apr 1;21(4):307-315. doi: 10.1158/1541-7786.MCR-22-0736. Mol Cancer Res. 2023. PMID: 36608299 Free PMC article.
[18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response.
Zhang H, Abou D, Lu P, Hasson AM, Villmer A, Benabdallah N, Jiang W, Ulmert D, Carlin S, Rogers BE, Turtle NF, McDevitt MR, Baumann B, Simons BW, Dehdashti F, Zhou D, Thorek DLJ. Zhang H, et al. Among authors: mcdevitt mr. Sci Rep. 2022 Jul 29;12(1):13034. doi: 10.1038/s41598-022-17460-0. Sci Rep. 2022. PMID: 35906379 Free PMC article.
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Rosenblat TL, McDevitt MR, Carrasquillo JA, Pandit-Taskar N, Frattini MG, Maslak PG, Park JH, Douer D, Cicic D, Larson SM, Scheinberg DA, Jurcic JG. Rosenblat TL, et al. Among authors: mcdevitt mr. Clin Cancer Res. 2022 May 13;28(10):2030-2037. doi: 10.1158/1078-0432.CCR-21-3712. Clin Cancer Res. 2022. PMID: 35247915 Free PMC article. Clinical Trial.
[89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Krebs S, Grommes C, McDevitt MR, Carlin SD, O'Donoghue JA, Graham MS, Young RJ, Schöder H, Gutin PH, Bander NH, Osborne JR. Krebs S, et al. Among authors: mcdevitt mr. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):783-785. doi: 10.1007/s00259-021-05543-5. Epub 2021 Sep 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 34498111 No abstract available.
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications.
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, Burnes Vargas D, Kubik TZ, Monette S, Santich BH, Yang G, Ouerfelli O, Kesner AL, Cheung NV, Scheinberg DA, Larson SM, Krebs S. Dacek MM, et al. Among authors: mcdevitt mr. Bioconjug Chem. 2021 Apr 21;32(4):649-654. doi: 10.1021/acs.bioconjchem.0c00595. Epub 2021 Apr 5. Bioconjug Chem. 2021. PMID: 33819023 Free PMC article.
88 results